AACR logo

More articles from Familial Breast Cancer - Genetic Testing

Abstract P6-08-28: Comprehensive germline multigene panel testing changes clinical care for patients with breast cancer
Peter Beitsch, Pat Whitworth, Kevin Hughes, Ian Grady, Karen Barbosa, Rakesh Patel, Michael Kinney, Paul Baron, Barry Rosen, Gia Compagnoni, Linda ann Smith, Rache Simmons, Cynara Coomer, Dennis Holmes, Eric Brown, Linsey Gold, Lisa Curcio, Patricia Clark, Tony Ruiz, Heather MacDonald, Sadia Khan, Lee Riley, Sam Lyons, Shan Yang, Mary K Hardwick, Edward D Esplin, Robert L Nussbaum

Cancer Research Feb 2020, 80 (4 Supplement) P6-08-28; DOI: 10.1158/1538-7445.SABCS19-P6-08-28
Abstract P6-08-26: Clinical characteristics of breast cancer patients with ATM mutations
Loredana Militello, Angelica M Gutierrez Barrera, Constance Albarracin, Isabelle Bedrosian, Banu K Arun

Cancer Research Feb 2020, 80 (4 Supplement) P6-08-26; DOI: 10.1158/1538-7445.SABCS19-P6-08-26
Abstract P6-08-22: Racial and ethnic variation in multi-gene panel genetic test results among individuals referred for genetic counseling at a large urban comprehensive cancer center
Michael Steven Simon, Nadine Abdallah, Hadeel Assad, Malini Surapaneni, Rachel Reagle, Nancie Petrucelli, Kristen Purrington

Cancer Research Feb 2020, 80 (4 Supplement) P6-08-22; DOI: 10.1158/1538-7445.SABCS19-P6-08-22
Abstract P6-08-17: When BRCA2-breast cancer is more prevalent than BRCA1-breast cancer: Prospective follow-up data from a multidisciplinary program
Catarina Bexiga, Priscila Nejo, Inês Oliveira, Paula Rodrigues, Patrícia Pereira, Sofia Fragoso, Alexandra Mayer, Joana Parreira, Sidónia Santos, Pedro Louro, Ana Luís, Sandra Bento, Isália Miguel, Cecília Moura, Ana Clara, Fátima Vaz

Cancer Research Feb 2020, 80 (4 Supplement) P6-08-17; DOI: 10.1158/1538-7445.SABCS19-P6-08-17
Abstract P6-08-38: Evaluation of adherence to NCCN guidelines regarding genetic evaluation of patients with breast or ovarian cancer diagnoses in a community hospital setting
Kristine M. King, Shannon Huffaker, Dione Froman

Cancer Research Feb 2020, 80 (4 Supplement) P6-08-38; DOI: 10.1158/1538-7445.SABCS19-P6-08-38
Abstract P6-08-36: Uptake of preventive surgeries in a prospective cohort of BRCA1/2 healthy women
Priscila Nejo, Catarina Bexiga, S. Fragoso, A Mayer, S Santos, P Louro, A Luis, C Moura, Ana Clara, Fatima Vaz

Cancer Research Feb 2020, 80 (4 Supplement) P6-08-36; DOI: 10.1158/1538-7445.SABCS19-P6-08-36
Abstract P6-08-35: Impact of multigene panel testing on medical management: Preliminary pre- and post-test clinician survey results
Carolyn Horton, Holly LaDuca, Mary H Black, Mary Pritzlaff, Jessica Profato, Kyle Allen, Jill S. Dolinsky

Cancer Research Feb 2020, 80 (4 Supplement) P6-08-35; DOI: 10.1158/1538-7445.SABCS19-P6-08-35
Abstract P6-08-31: BRCA1 interacting protein C-terminal helicase 1 (BRIP1) as a cancer susceptibility gene
Mukul Singal, Manasi M Godbole, Kim Povenzano, Beth Elmore, Mehul P Patel

Cancer Research Feb 2020, 80 (4 Supplement) P6-08-31; DOI: 10.1158/1538-7445.SABCS19-P6-08-31
Abstract P6-08-39: Hereditary cancer risk assessment using a chatbot in women presenting to obstetrics and gynecology practices across the U.S.
Lindsay Dohany, Heidi Owen, Ashley Reeves, Christina Settler

Cancer Research Feb 2020, 80 (4 Supplement) P6-08-39; DOI: 10.1158/1538-7445.SABCS19-P6-08-39
Abstract P6-08-01: Comparison of recommendations for germline genetic testing in an unselected cohort of patients with breast cancer
Siddhartha Yadav, Chunling Hu, Steven N. Hart, Nicholas Boddicker, Eric C. Polley, Jie Na, Rohan Gnanaolivu, Kun Y. Lee, Janet E. Olson, Kathryn J. Ruddy, Fergus J. Couch

Cancer Research Feb 2020, 80 (4 Supplement) P6-08-01; DOI: 10.1158/1538-7445.SABCS19-P6-08-01

Main menu

User menu

Search

More articles from Familial Breast Cancer - Genetic Testing

Pages

Articles

Info for

About Cancer Research